Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05282394 · ClinicalTrials.gov registry record · NA
Newborn Abdominal Massage to Prevent Hyperbilirubinemia
A NA study of Newborn Jaundice, sponsored by University of California, Davis.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05282394: Active NA study of Newborn Jaundice, sponsored by University of California, Davis.
NCT05282394 is a NA study of Newborn Jaundice that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05282394, a NA study of Newborn Jaundice, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study will incorporate an intervention previously un-studied in the US healthcare setting for prevention of hyperbilirubinemia
Primary Outcome
Acceptability of the intervention will be defined by the 1-sided 95% confidence interval for the proportion of the intervention group performing massage at least once to include 80% and for the 1-sided 95% confidence interval for at the proportion performing massage as directed to include 70%.
Conditions Studied
Interventions
- PROCEDURE Abdominal massage
- OTHER Reading
Study Locations (1)
California
- University of California-Davis - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05282394 still lists
NCT05282394 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Newborn Jaundice appearing as the primary indexed condition, and to 2 interventions - of which Abdominal massage is the first listed.
NCT05282394 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05282394 about?
NCT05282394 is a clinical study titled "Newborn Abdominal Massage to Prevent Hyperbilirubinemia". The proposed study will incorporate an intervention previously un-studied in the US healthcare setting for prevention of hyperbilirubinemia
What is the current status of trial NCT05282394?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-08-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05282394 study?
This clinical trial studies the following conditions: Newborn Jaundice.
What interventions are being tested in trial NCT05282394?
The interventions under investigation include: Abdominal massage (PROCEDURE), Reading (OTHER).
Who is sponsoring clinical trial NCT05282394?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05282394 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05282394's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI